Health Ministry of Health

Madrid, Spain

Health Ministry of Health

Madrid, Spain

Time filter

Source Type

PubMed | d Research Unit of Spanish Rheumatology Scientific Society, General Directorate of Health Research, A Aets Agencia Of Evaluacion Of Tecnologias Sanitarias Health Technology Assessment Agency, B Ludwig Boltzmann Institute For Health Technology Assessment and Health Ministry of Health
Type: Journal Article | Journal: Expert review of medical devices | Year: 2016

Esophageal stents are used for the treatment of refractory and recurrent dyphagias. In 2007, esophageal biodegradable stents (EBS) were authorised as an alternative to existing metal and plastic stents in Europe. The advantages claimed for EBS are fewer complications concerning tissue ingrowth, stent migration and stent removal.We performed a systematic review to evaluate the efficacy and safety of EBS compared to fully-covered self-expanding metal stents, self-expanding plastic stents, and esophageal dilation for the treatment of refractory or recurrent benign esophageal stenosis. Three comparative studies (one randomized controlled trial and two cohort studies) were assessed. The studies used different inclusion criteria, had a very small (sample) size and the quality of the evidence was very low. Expert commentary: The current evidence is insufficient to determine the relative efficacy or safety of esophageal biodegradable stents. The results of this systematic review should be updated once new evidence is available.


Imaz-Iglesia I.,Aets Agencia Of Evaluacion Of Tecnologias Sanitarias Health Technology Assessment Agency | Garcia-Perez S.,Aets Agencia Of Evaluacion Of Tecnologias Sanitarias Health Technology Assessment Agency | Nachtnebel A.,Ludwig Boltzmann Institute For Health Technology Assessment | Martin-Agueda B.,Health Ministry of Health | And 3 more authors.
Expert Review of Medical Devices | Year: 2016

Introduction: Esophageal stents are used for the treatment of refractory and recurrent dyphagias. In 2007, esophageal biodegradable stents (EBS) were authorised as an alternative to existing metal and plastic stents in Europe. The advantages claimed for EBS are fewer complications concerning tissue ingrowth, stent migration and stent removal. Areas covered: We performed a systematic review to evaluate the efficacy and safety of EBS compared to fully-covered self-expanding metal stents, self-expanding plastic stents, and esophageal dilation for the treatment of refractory or recurrent benign esophageal stenosis. Three comparative studies (one randomized controlled trial and two cohort studies) were assessed. The studies used different inclusion criteria, had a very small (sample) size and the quality of the evidence was very low. Expert commentary: The current evidence is insufficient to determine the relative efficacy or safety of esophageal biodegradable stents. The results of this systematic review should be updated once new evidence is available. © 2016 Informa UK Limited, trading as Taylor & Francis Group.

Loading Health Ministry of Health collaborators
Loading Health Ministry of Health collaborators